News
IDXX
476.60
-0.34%
-1.64
The Implied Analyst 12-Month Target For IVW
NASDAQ · 1d ago
$1000 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth This Much Today
IDEXX Laboratories has outperformed the market over the past 10 years by 13.2% on an annualized basis. The company has an average annual return of 23.57%. If an investor bought $1000 of IDXX stock 10 years ago it would be worth $8,332.54 today.
Benzinga · 2d ago
Commit To Buy Idexx Laboratories At $320, Earn 1.4% Annualized Using Options
NASDAQ · 2d ago
Weekly Report: what happened at IDXX last week (0408-0412)?
Weekly Report · 3d ago
IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet
IDEXX Laboratories, Inc. (NASDAQ:IDXX) does carry debt, but is this a concern for shareholders? Debt can be a good thing for a company to use to shore up its balance sheet. The medical equipment company has a very light debt load and is able to pay off its debt with free cash flow. Its net debt is only 0.41 times its earnings, and its EBIT covers its interest expense 30.5 times over. IDEXX labs has a healthy balance sheet, but it does carry a large amount of debt.
Simply Wall St · 04/11 16:56
Elevance Health (ELV) Brand Inks Deal to Better Serve Georgia
NASDAQ · 04/09 18:13
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Inozyme Pharma (INZY), Zai Lab (ZLAB) and Idexx Laboratories (IDXX)
TipRanks · 04/09 10:20
Weekly Report: what happened at IDXX last week (0401-0405)?
Weekly Report · 04/08 09:27
IDEXX: Strong Recurring Revenues From Consumables, Software But Overvalued (Rating Downgrade)
Home Healthcare IDEXX: Strong Recurring Revenues From Consumables, Software and Diagnostic Imaging But Overvalued. The company has experienced double-digit growth in consumables, software, and diagnostic imaging. While IDEXx's business is strong, the stock price is considered overvalued. Wolf Research has a 'Hold' rating with a one-year price target of $420 per share.
Seeking Alpha · 04/08 08:29
Press Release: IDEXX Laboratories to Release 2024 First Quarter Financial Results
IDEXX Laboratories to Release 2024 First Quarter Financial Results on May 1, 2024. The Company is a global leader in pet healthcare innovation. The company will release its 2024 first quarter results before the market opens on Wednesday, May 1. A live webcast of the conference call will be available on the company's website.
Dow Jones · 04/04 20:35
Stock winners of Republican policy if Trump wins - GS
Stock winners of Republican policy if Trump wins. Goldman Sachs report listed stocks that are constituents of GOP policy in several industries and sectors. In financials, companies would benefit from easing capital rules and antitrust. In border protection, the companies involved in the construction of tighter borders would benefit.
Seeking Alpha · 04/03 19:21
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
NASDAQ · 04/03 12:50
Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now
NASDAQ · 04/02 12:31
Investor Activism: Elanco Animal Health Settles with Ancora, Adds New Board Members
Elanco Animal Health Inc has reached a settlement with activist investor Ancora. The settlement will expand the board to 14 members. Elanco owns approximately 3% of the outstanding common stock of Elanco. The activist investor had been advocating for changes in the company's corporate governance.
Benzinga · 04/01 12:45
UPDATE 1-Elanco appoints two directors after settling with activist Ancora
Elanco Animal Health appoints two directors after reaching agreement with activist investor Ancora Holdings. The company makes medicines and vaccinations for pets and livestock. The investment firm had said in February it wanted four board seats at Elanco and to replace CEO Jeffrey Simmons. Elanco stopped short of appointing a CEO.
Reuters · 04/01 11:00
Elanco appoints two directors to its board after agreement with Ancora
Elanco appoints two directors to its board after agreement with Ancora Holdings. Elanco Animal Health appointed two independent directors to board. The two directors were appointed by investment firm AnCora Holdings, Elanco says. The animal health company says it has agreed to appoint the independent directors.
Reuters · 04/01 10:39
Weekly Report: what happened at IDXX last week (0325-0329)?
Weekly Report · 04/01 09:27
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 20 Years
IDEXX Laboratories has outperformed the market over the past 20 years by 3.81% on an annualized basis. The company has an average annual return of 11.64%. If an investor bought $100 of IDXX stock 20 years ago, it would be worth $901.28 today.
Benzinga · 03/27 18:30
Investing in IDEXX Laboratories (NASDAQ:IDXX) five years ago would have delivered you a 136% gain
The price of IDEXX Laboratories, Inc. Stock is up 136% over the last five years. Over half a decade, the company has grown its earnings per share at 19% a year. The share price has roughly tracked the growth of the company's earnings over the longer term. The company's share price is now up over 100% from its IPO price. The company has been consistent with shareholders returns over the years.
Simply Wall St · 03/27 10:15
Top Research Reports for Lam Research, PayPal & Trane
NASDAQ · 03/25 22:30
More
Webull provides a variety of real-time IDXX stock news. You can receive the latest news about IDEXX Laboratories through multiple platforms. This information may help you make smarter investment decisions.
About IDXX
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.